Segui
Cortesi Laura
Cortesi Laura
Affiliazione sconosciuta
Email verificata su unimore.it
Titolo
Citata da
Citata da
Anno
Multicenter Comparative Multimodality Surveillance of Women at Genetic-Familial High Risk for Breast Cancer (HIBCRIT Study): Interim Results1
F Sardanelli, F Podo, G D'Agnolo, A Verdecchia, M Santaquilani, ...
Radiology 242 (3), 698-715, 2007
4362007
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally …
D Miles, J Gligorov, F André, D Cameron, A Schneeweiss, C Barrios, B Xu, ...
Annals of Oncology 32 (8), 994-1004, 2021
4192021
Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast …
F Sardanelli, F Podo, F Santoro, S Manoukian, S Bergonzi, G Trecate, ...
Investigative radiology 46 (2), 94-105, 2011
3742011
Hereditary ovarian cancer: not only BRCA 1 and 2 genes
A Toss, C Tomasello, E Razzaboni, G Contu, G Grandi, A Cagnacci, ...
BioMed research international 2015, 2015
2972015
An overview of PARP inhibitors for the treatment of breast cancer
L Cortesi, HS Rugo, C Jackisch
Targeted oncology 16 (3), 255-282, 2021
2282021
The Italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk
F Podo, F Sardanelli, R Canese, G D'Agnolo, PG Natali, M Crecco, ...
Journal of Experimental & Clinical Cancer Research 21, 115-124, 2002
2072002
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ...
Journal of Clinical Oncology 35 (20), 2240, 2017
1912017
Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia
A DeCensi, M Puntoni, A Guerrieri-Gonzaga, S Caviglia, F Avino, ...
Journal of Clinical Oncology 37 (19), 1629, 2019
1712019
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
CE Geyer Jr, JE Garber, RD Gelber, G Yothers, M Taboada, L Ross, ...
Annals of oncology 33 (12), 1250-1268, 2022
1552022
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
V Silvestri, D Barrowdale, AM Mulligan, SL Neuhausen, S Fox, BY Karlan, ...
Breast Cancer Research 18, 1-13, 2016
1442016
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
MT Parsons, E Tudini, H Li, E Hahnen, B Wappenschmidt, L Feliubadaló, ...
Human mutation 40 (9), 1557-1578, 2019
1202019
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy
L Ottini, V Silvestri, P Rizzolo, M Falchetti, I Zanna, C Saieva, G Masala, ...
Breast cancer research and treatment 134, 411-418, 2012
1102012
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor
P Peterlongo, I Catucci, M Colombo, L Caleca, E Mucaki, M Bogliolo, ...
Human molecular genetics 24 (18), 5345-5355, 2015
1042015
Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population‐based study
L Monesi, M Baviera, I Marzona, F Avanzini, G Monesi, A Nobili, ...
Diabetic medicine 29 (3), 385-392, 2012
982012
The association between endometriomas and ovarian cancer: preventive effect of inhibiting ovulation and menstruation during reproductive life
G Grandi, A Toss, L Cortesi, L Botticelli, A Volpe, A Cagnacci
BioMed research international 2015, 2015
942015
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
A Toss, C Isca, M Venturelli, C Nasso, G Ficarra, V Bellelli, C Armocida, ...
ESMO open 6 (2), 100055, 2021
892021
Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations
M Lambertini, L Ameye, AS Hamy, A Zingarello, PD Poorvu, E Carrasco, ...
Journal of Clinical Oncology 38 (26), 3012-3023, 2020
822020
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients
MV Lenti, L Pasina, S Cococcia, L Cortesi, E Miceli, CC Dominioni, ...
European Journal of Internal Medicine 61, 54-61, 2019
802019
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience
L Cortesi, D Turchetti, I Marchi, A Fracca, B Canossi, R Battista, S Ruscelli, ...
BMC cancer 6, 1-9, 2006
742006
Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
C Omarini, G Guaitoli, S Pipitone, L Moscetti, L Cortesi, S Cascinu, ...
Cancer management and research, 91-103, 2018
722018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20